Look at the weekly trend line, not any single reading
Prymula R, Siegrist CA, Chlibek R, Zemlickova H, Vackova M, Smetana J, et al
A clinical trial will enable researchers to take a deeper look into exactly how GLP-1 medications might reduce cancer risk or prevent tumor progression, McDonald said
Some Aetna plans in Arizona may cover GLP-1 medications for weight loss when prescribed for a qualifying diagnosis and approved through prior authorization
That said, some patients reported the following side effects: Anxiety due to a drop in blood sugar Headaches Darkened urine Fast heartbeat Injection site reactions (pain, redness, etc) Gas and increased potency of gas (their poop smelled) Some other adverse reactions have been reported by individuals, but these are individual reactions that have not been found in other treated patients
For retatrutide, there is no FDA label yet, but the Phase 3 trial protocols follow similar missed-dose logic